Roivant Sciences Ltd (ROIV)
Cash ratio
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 2,715,410 | 1,990,680 | 1,969,910 | 5,678,510 | 6,535,710 | 6,670,810 | 1,408,230 | 1,434,090 | 1,676,810 | 1,531,400 | 1,599,020 | 1,942,220 | 2,060,400 | 2,214,280 | 2,497,330 | 1,996,730 | 2,055,040 | — |
| Short-term investments | US$ in thousands | 2,171,480 | 3,155,820 | 3,428,020 | -9,377 | 5,367 | 5,165 | 5,474 | -10,291 | 15,302 | 13,600 | — | — | 13,634 | 11,852 | — | — | — | — |
| Total current liabilities | US$ in thousands | 149,411 | 141,484 | 556,249 | 215,045 | 266,758 | 244,899 | 265,546 | 245,004 | 272,448 | 244,255 | 230,744 | 328,915 | 184,367 | 160,713 | 303,444 | 209,158 | 218,961 | — |
| Cash ratio | 32.71 | 36.38 | 9.70 | 26.36 | 24.52 | 27.26 | 5.32 | 5.81 | 6.21 | 6.33 | 6.93 | 5.90 | 11.25 | 13.85 | 8.23 | 9.55 | 9.39 | — |
March 31, 2025 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($2,715,410K
+ $2,171,480K)
÷ $149,411K
= 32.71
The cash ratio of Roivant Sciences Ltd has shown fluctuations over the years based on the provided data. The cash ratio measures the company's ability to cover its short-term liabilities with its available cash and cash equivalents.
From December 31, 2020, to June 30, 2022, the cash ratio exhibited an increasing trend, indicating that the company had more liquid assets available to meet its short-term obligations during this period. However, from June 30, 2022, to June 30, 2023, the cash ratio experienced a decline, signaling a potential decrease in the company's ability to cover its short-term liabilities with cash.
The cash ratio spiked significantly by the end of December 31, 2023, and continued to remain high until December 31, 2024. This substantial increase might imply that Roivant Sciences Ltd significantly boosted its cash reserves during this period, potentially strengthening its liquidity position.
Overall, the cash ratio of Roivant Sciences Ltd has shown varying levels, reflecting fluctuations in the company's available cash and short-term liabilities over the years. Analyzing this ratio alongside other financial metrics can provide a more comprehensive understanding of the company's liquidity and financial health.
Peer comparison
Mar 31, 2025